Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Amarantus Bioscience Holdings (AMBS) Message Board

I don't know about anyone who knows, but I think,

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 30067
(Total Views: 434)
Posted On: 03/28/2018 9:18:58 PM
Avatar
Posted By: freegriff
Re: longboardsurfer90210 #26399
I don't know about anyone who knows, but I think, therefore I answer your tangled set of ?s
1. Reg A+ and the JOBS act are new, with even newer expansions, amendments etc. In addition, in the vast world of fundraising, certain means go through cycles where they become popular, which is key to attracting the necessary expertise and trust in the process. Further, the macro economic situation is supportive. 2016 was awful generally.
2. For Elto, a clear path to approval and the metrics of the competing product became clear only in late 2017. Clearly the market is signaling that we have a chance at getting the product to market and that the product could be competitive or superior. The ball didn't really get rolling until then. No coincidence that this cockamamy plan was agreed to in principle mear months later.
3. I believe we tried to do this exact thing in 2015 when it got all muffed up. I cannot wait to find out what happened behind the scenes.
4. Product wise I'm not here for Elto, or ESS, though I wish them well. But ESS lacks elegance and a major market. It's a mix-use zoned commercial building. Elto is the $200,000 suburban house of biotech. Standard, simple story worth taking a shot at, and you know what if we can throw in some granite counter tops and a pool later, we'll be sitting pretty.
5. You as an investor have X shares in AMBS. AMBS has 3ish subs. For simplicity's sake, you do not benefit if you sell 1/3 of your shares for 1/3 of the present value of the shares. But if you as a legacy holder recieve a distibution, a spin off, a dividend such that you're in effect only giving up 1/6 of your shares at 1/3 of the value, you have doubled your money. I am not an 8 ball. I don't know exactly what the future holds, but spinoffs happen all the time. Reg A+ stories exist and are researchable. Company's like Elto that go public at public valuations far in excess of the original private investments, which is essentially what you have, happen all the time. Early private investors always get rich at the IPO. We just have to do the damn thing.
6. Further multiplying the value to you will be that the success of the sub, not creates a better negotiating position for the wammy bar- MANF. Which by the way is being de-risked for us, free of charge, by Herantis and universities around the world.
7. All of this you must weigh against the probability that we cannot buy back any or all of the New Prefered conversions scheduled to start at the end of the year, due to incompetence, trickery, bad luck, a bad market, everything on the boiler plate etc.


(6)
(0)




Amarantus Bioscience Holdings (AMBS) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us